Veeva Systems (VEEV)
(Delayed Data from NYSE)
$281.35 USD
-2.85 (-1.00%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $281.29 -0.06 (-0.02%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth C Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Veeva Systems Inc. has a PEG ratio of 1.72 compared to the Medical Info Systems industry's PEG ratio of 2.78.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
VEEV 281.35 -2.85(-1.00%)
Will VEEV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for VEEV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for VEEV
Veeva Systems (VEEV) Stock Moves -1.09%: What You Should Know
Can Veeva's Vault R&D Keep Its Lead Amid Rising AI Competition?
VEEV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's Why Veeva Systems (VEEV) is a Strong Growth Stock
Wall Street Analysts See Veeva (VEEV) as a Buy: Should You Invest?
Does OptimizeRx Have a Moat in the Crowded HealthTech Space?
Other News for VEEV
Franklin Small-Mid Cap Growth Fund Q2 2025 Commentary
Survey Finds Medtechs Lack Confidence in Regulatory Data Quality | VEEV Stock News
Veeva Systems Larger Than S&P 500 Component Target
Veeva Systems Reaches Analyst Target Price
Cathie Wood's Ark Invest Loads Up On Absci, Offloads CRISPR Therapeutics